CAS: 350-03-8; 1-(Pyridin-3-yl)Ethanone

相似化合物

5973-83-1 4754-27-2 95091-91-1

上下游产品

CAS号4754-27-2 3-(1-羟乙基)吡啶 | CAS号626-55-1 3-溴吡啶 | CAS号75-36-5 乙酰氯 | CAS号111-34-2 乙烯基正丁醚 | CAS号764-78-3 乙二醇二乙烯醚 | CAS号626-60-8 3-氯吡啶 | CAS号109-92-2 乙烯基乙醚 | CAS号32064-90-7 bis-(1-pyridin-... | CAS号14188-94-4 3-乙酰基吡啶 N-氧化物 | CAS号30510-18-0 3-氧代-3-(3-吡啶基)丙腈 | CAS号104501-58-8 1-Trimethylsily... | CAS号111781-56-7 2-PYRIDIN-3-YL ... | CAS号107445-24-9 2,2-Diethoxy-2-... | CAS号106881-77-0 Ethanone, 1-(3-... | CAS号33284-21-8 3-三氟乙酰基吡啶 | CAS号494-98-4 2-(3-吡啶基)1H-吡咯 | CAS号5973-83-1 1-(3-吡啶l)乙-1-酮肟 | CAS号56129-55-6 1-(3-吡啶)乙胺 | CAS号5109-99-9 6-BROMO-2-PYRID...

3-(Prop-1-En-2-yl)Pyridine置于sodium Anthraquinone-2-Sulfonate,水体系中,用 乙腈 用作溶剂,以96%的收率获得3-乙酰基吡啶
参考文献:烯烃的光催化氧化裂解和羰基立体选择性生物还原合成对映体富集的仲醇
标题:烯烃的光催化氧化裂解和羰基立体选择性生物还原合成对映体富集的仲醇
摘要:介绍 传统上,通过基于在极低温度下原位产生臭氧作为终端氧化剂的臭氧分解反应来进行烯烃的氧化裂解以产生二羰基化合物.1与臭氧化物和过氧化物形成相关的危害,特别是在下游工艺过程中,废物产生量高,需要专用设备以及在存在其他官能团的情况下缺乏选择性,提醒需要披露更安全和可持续的烯烃臭氧分解替代品.在这种情况下,使用其他氧化物质,如 Kmno 4,Naio 4,Hio 4,Oso 4,叔丁基氢过氧化物,过硫酸氢钾...... 2种金属催化的氧化裂解(co,Mn,Ru,Fe......),2B,3以及涉及非血红素和血红素铁依赖性蛋白的酶转化,4为制备多种醛和酮提供了多种可能性.从2001年起,在甲氧基苯作为敏化剂的存在下,使用分子氧进行α-甲基苯乙烯的光诱导氧化是已知的.5后来,由于自然界中存在丰富的可见光,光诱导烯烃氧化裂解反应6的性能,包括金属催化(cu,Ru,Ir...),使用有机染料和酶的无金属转化,受到越来越
Doi:10.1002/adsc.202301325

专利信息

专利号:US-9388131-B2
优先权日:2011-04-27
标题:Automated synthesis of small molecules using chiral, non-racemic boronates
发明人：BURKE MARTIN D; LI JUNQI; GILLIS ERIC P
权利人:UNIV ILLINOIS
摘要:Provided are methods for making and using chiral, non-racemic protected organoboronic acids, including pinene-derived iminodiacetic acid (PIDA) boronates, to direct and enable stereoselective synthesis of organic molecules. Also provided are methods for purifying PIDA boronates from solution. Also provided are methods for deprotection of boronic acids from their PIDA ligands. The purification and deprotection methods may be used in conjunction with methods for coupling or otherwise reacting boronic acids. Iterative cycles of deprotection, coupling, and purification can be performed to synthesize chiral, non-racemic compounds. The methods are suitable for use in an automated chemical synthesis process. Also provided is an automated small molecule synthesizer apparatus for performing automated stereoselective synthesis of chiral, non-racemic small molecules using iterative cycles of deprotection, coupling, and purification.

专利号:US-7692019-B2
优先权日:2000-12-04
标 题:Methods for the stereoselective synthesis of substituted piperidines
发明人：AQUILA BRIAN M; BANNISTER THOMAS D; CUNY GREGORY D; HAUSKE JAMES R; HEFFERNAN MICHELE L R; HOEMANN MICHAEL Z; KESSLER DONALD W; SHAO LIMING; WU XINHE; XIE ROGER L
权利人:SEPRACOR INC
摘要:One aspect of the present invention relates to methods of synthesizing substituted piperidines. A second aspect of the present invention relates to stereoselective methods of synthesizing substituted piperidines. The methods of the present invention will find use in the synthesis of compounds useful for treatment of numerous ailments, conditions and diseases that afflict mammals, including but not limited to addiction and pain. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the substituted piperidines using the methods of the present invention. An additional aspect of the present invention relates to enantiomerically substituted pyrrolidines, piperidines, and azepines.

专利号:US-8334381-B2
优先权日:2006-11-16
标题 :Process for the preparation of intermediates useful in the synthesis of imatinib
发明人：FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO
权利人:FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO; ITALIANA SINT SPA
摘要:It is the object of the present invention a process for the preparation of 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine and analogues thereof, intermediates useful for the synthesis of Imatinib, or 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide.

专利号:WO-2012088402-A1
优先权日:2010-12-22
标题 :Synthesis of conolidine and discovery of a potent non-opioid analgesic for pain
发明人：BOHN LAURA M; MICALIZIO GLENN C
权利人:SCRIPPS RESEARCH INST; BOHN LAURA M; MICALIZIO GLENN C
摘要:The first de novo synthetic pathway to the exceptionally rare C5-nor stemmadenine natural product, conolidine, and the first asymmetric synthesis of any member of this natural product class arc described. C5-nor stemmadenine compositions are also described. These compounds, for example,(+/- )-,(+)- and (-)-conolidine are potent and efficacious non-opioid analgesics in tonic and persistent pain.

专利号:US-6413957-B1
优先权日:1998-04-21
标题:Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones
发明人：NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
权利人:BRISTOL MYERS SUIBB PHARMA COM
摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

专利号:US-8728750-B2
优先权日:2006-09-06
标 题 :Process for preparation of optically active N-protected 3-aminopyrrolidine or optically active N-protected 3-aminopiperidine and the corresponding ketones by optical resolution of the racemic amine mixtures employing a bacterial omega-transaminase
发明人：ROBINS KAREN; BORNSCHEUER UWE; HÖHNE MATTHIAS
权利人:ROBINS KAREN; BORNSCHEUER UWE; HÖHNE MATTHIAS; LONZA AG
摘要:The present invention relates to the production of optically active amines, which can be used as intermediate products in a synthesis of for instance pharmaceutical products.